as on November 15, 2025 at 2:29 am IST
Day's Low
Day's High
1.68%
Downside
3.95%
Upside
52 Week's Low
52 Week's High
29.11%
Downside
42.32%
Upside
Check Cellebrite Di Ltd. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$3.9B
EPS (TTM)
0.4855
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
-0.77%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
74.5M
Revenue (TTM)
436.7M
Profit Margin
-34.56%
Return On Equity TTM
-81.98%
Compare market cap, revenue, PE, and other key metrics of Cellebrite Di Ltd. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $3.9B | NA | NA | -34.56% | |
| HOLD | $439.0B | 989.49% | 438.5 | 28.11% | |
| BUY | $137.0B | 300.8% | 476.42 | -6.84% | |
| BUY | $647.1B | 282.31% | 52.54 | 21.08% | |
| BUY | $143.7B | 374.92% | 132.1 | 12.30% |
The Cellebrite Di Ltd. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Cellebrite Di Ltd. investment value today
Current value as on today
₹1,08,090
Returns
₹8,090
(+8.09%)
Returns from Cellebrite Di Ltd. Stock
₹2,895 (+2.9%)
Dollar Returns*
₹5,194 (+5.19%)
Based on 14 analysts
92.86%
Buy
7.14%
Hold
0.00%
Sell
Based on 14 analysts, 92.86% of analysts recommend a 'BUY' rating for Cellebrite Di Ltd.. Average target price of $23.57
Get share price movements and forecasts by analysts on Cellebrite Di Ltd..
What analysts predicted
21.6%UPSIDE
Target Price
$23.57
Current Price
$18.48
Analyzed by
14 Analysts
Target
$23.57
Cellebrite Di Ltd. target price $23.57, a slight upside of 21.6% compared to current price of $18.48. According to 14 analysts rating.
Search interest for Cellebrite Di Ltd. Stock has increased by 56% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:56% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 13 November
Thu, 05:52 PM
-Bank of America reiterates Buy rating on Cellebrite, highlighting recovery in Federal demand and growth potential.
Thu, 08:52 PM
-William Blair maintains Buy rating on CLBT, citing strong financial performance and promising growth prospects.
Thu, 10:48 PM
-Cellebrite stock climbs 23% after earnings beat expectations, with revenue and adjusted EBITDA also exceeding forecasts.
Today's Timeline - 13 November
Thu, 11:51 PM
-Cellebrite reports strong Q3 results, raising full-year sales and ARR targets, boosting investor confidence.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 7 days, CLBT stock has moved up by 25.2%
Profit Spike
![]()
Netprofit is up for the last 2 quarters, 17.4M → 19.47M (in $), with an average increase of 10.7% per quarter
Revenue Rich
![]()
Revenue is up for the last 2 quarters, 107.54M → 113.27M (in $), with an average increase of 5.1% per quarter
Against Peers
![]()
In the last 1 year, Palantir Technologies Inc has given 190.9% return, outperforming this stock by 183.6%
Against Peers
![]()
In the last 3 years, Palantir Technologies Inc has given 2025.2% return, outperforming this stock by 1727.7%
| Organisation | Cellebrite Di Ltd. |
| Headquarters | 94 Shlomo Shmelzer Road, Petah Tikva, Israel, 4970602 |
| Industry | Technology |
| CEO | Mr. Thomas E. Hogan |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. David Nicholas Gee | Chief Marketing Officer |
Ms. Zohar Tadmor-Eilat | Chief People Officer |
Mr. Ronnen Armon | Chief Products & Technologies Officer |
Mr. David Barter | Chief Financial Officer |
Ms. Sigalit Shavit | Chief Information Officer |
Ms. Holly B. Windham Esq., J.D. | General Counsel & Chief Compliance Officer |
Mr. Thomas E. Hogan | CEO & Director |
Mr. Yossi Carmil | Founder |
Mr. Marcus Jewell | Global Chief Revenue Officer |
Andrew Kramer | Vice President of Investor Relations |
Cellebrite Di Ltd. share price today is $18.48 as on at the close of the market. Cellebrite Di Ltd. share today touched a day high of $19.21 and a low of $18.17.
Cellebrite Di Ltd. share touched a 52 week high of $26.3 on and a 52 week low of $13.1 on . Cellebrite Di Ltd. stock price today i.e. is closed at $18.48,which is 29.73% down from its 52 week high and 41.07% up from its 52 week low.
Cellebrite Di Ltd. market capitalisation is $0.00T as on .
Indian investors can start investing in Cellebrite Di Ltd. (CLBT) shares with as little as ₹88.7 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹887.00 in Cellebrite Di Ltd. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Cellebrite Di Ltd. share’s latest price of $18.48 as on November 15, 2025 at 2:29 am IST, you will get 0.5411 shares of Cellebrite Di Ltd.. Learn more about
fractional shares .